A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function

Clinical trial NCT05760300 · COMPLETED

Trial details

NCT number: NCT05760300
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis D Infection

Start date: 2023-03-15
Primary completion: 2024-07-18
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.